DOV Pharmaceuticals About
DOV DOV Pharmaceuticals is a biopharmaceutical company
focused on the discovery, in-licensing, development and commercialization of novel
drug candidates for central nervous system, and other disorders, including cardiovascular,
that involve alterations in neural processing. DOV has six product candidates
in clinical trials targeting
insomnia, anxiety disorders,
pain, depression
and angina and hypertension.
The Company has established strategic alliances with select partners in part to
access their unique technologies and commercialization capabilities. The Company
operates principally in the United States but also conducts clinical studies in
Canada and Europe. In 1998, DOV licensed four of their product candidates from
Wyeth: indiplon, for the treatment of insomnia,
bicifadine, for the treatment of pain,
ocinaplon, for the treatment of generalized anxiety
disorder, DOV 216,303, and DOV 21,947 for the treatment
of depression, anxiety
and substance abuse
. DOV Diltiazen
for Angina and Hypertension Product
Pipeline DOV Pharmaceuticals More
on DOV
Pharmaceuticals Key
Statistics for DOV Pharmaceuticals
Basic
Chart for DOV Pharmaceuticals